Faber Logo
Skip to main content
Pexels markus spiske 2004161 2022 11 01 201749 qflt

Client Groups

Digital Health, Software, SaaS, & IT Device Companies

Increasingly, the collection and exploitation of large data sets, and the leverage of complex software systems (including machine learning, organs-on-a-chip, and laboratory high-throughput automation) are changing pharmaceutical R&D.

Overview

At Faber, we've represented many emerging companies in Digital Health, Software, SaaS, & IT Devices spaces.

We have strong relationships with the investor groups that focus on these verticals and have advised many of them on transactions in these areas.

Our transactional experience includes a wide variety of commercial agreements, covering Digital Health, SaaS and cloud-based applications, enterprise software and implementation and more, including:

  • Digital health products
  • SaaS, software, and user applications
  • Complex hardware and equipment system sales, procurement, and support
  • Enterprise cloud content management systems, such as e-laboratory notebooks and electronic trial management systems
  • Systems integration and implement management services
  • Maintenance and development services
Lily Jacqui and Brian Talking
This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.